Your browser doesn't support javascript.
loading
Progression pattern and adverse events with bevacizumab in glioblastoma.
Mamo, A; Baig, A; Azam, M; Rho, Y S; Sahebjam, S; Muanza, T; Owen, S; Petrecca, K; Guiot, M C; Al-Shami, J; Sharma, R; Kavan, P.
Afiliação
  • Mamo A; Segal Cancer Centre, Jew ish General Hospital, McGill University, Montreal, QC.
  • Baig A; Segal Cancer Centre, Jew ish General Hospital, McGill University, Montreal, QC.
  • Azam M; Segal Cancer Centre, Jew ish General Hospital, McGill University, Montreal, QC.
  • Rho YS; Segal Cancer Centre, Jew ish General Hospital, McGill University, Montreal, QC.
  • Sahebjam S; Segal Cancer Centre, Jew ish General Hospital, McGill University, Montreal, QC.
  • Muanza T; Radiation Oncology, Jewish General Hospital, McGill University Health Centre, Montreal, QC.
  • Owen S; Department of Oncology, McGill University Health Centre, Montreal, QC.
  • Petrecca K; Neurosurgery, Montreal Neurological Institute, Montreal, QC.
  • Guiot MC; Pathology, McGill University Health Centre, Montreal, QC.
  • Al-Shami J; Clinical Research, McGill University Health Centre, Montreal, QC.
  • Sharma R; Clinical Research, McGill University Health Centre, Montreal, QC.
  • Kavan P; Segal Cancer Centre, Jew ish General Hospital, McGill University, Montreal, QC.
Curr Oncol ; 23(5): e468-e471, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27803607
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Curr Oncol Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Curr Oncol Ano de publicação: 2016 Tipo de documento: Article